What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?

BACKGROUND: Progressive multifocal leukoencephalopathy is a serious condition linked to certain diseases and immunosuppressant therapies, including the α(4) integrin antagonist natalizumab. No cases have been reported to date with vedolizumab, a selective antagonist of the α(4)β(7) integrin expresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Card, Timothy, Xu, Jing, Liang, Huifang, Bhayat, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
IBD Live
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176885/
https://www.ncbi.nlm.nih.gov/pubmed/29668955
http://dx.doi.org/10.1093/ibd/izx097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176885/
https://www.ncbi.nlm.nih.gov/pubmed/29668955
http://dx.doi.org/10.1093/ibd/izx097

Ejemplares similares